Search
for
Sort by
Research 661–690 of 1000+
- Mental Health as Assessed by the Symptom Checklist 90 (SCL-90) Scores in Women with and Without Polycystic Ovary Syndrome
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- Leveraging Multifaceted Polyphenol Interactions: An Approach for Hair Loss Mitigation
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups
- The Effects of Metformin, Ethinyl Estradiol/Cyproterone Acetate, and Metformin Ethinyl Estradiol/Cyproterone Acetate Combination Therapy on Carotid Artery Intima-media Thickness in Patients with Polycystic Ovary Syndrome
- Current Literature Review
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- AMALAKI (EMBLICA OFFICINALIS GAERTN.): AN INTEGRATIVE REVIEW AND META-ANALYSIS OF CLASSICAL AYURVEDIC PERSPECTIVES AND MODERN CLINICAL EVIDENCE
- associations between serum dihydrotestosterone levels, lipid parameters & anthropometric measurements in male patients with type 2 diabetes mellitus
- Role of insulin-like growth factor-1 receptor in female androgenetic alopecia
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Early-onset Male Androgenetic Alopecia and Metabolic Syndrome: Are They Associated?
- Advancements and Applications of Injectable Hydrogel Composites in Biomedical Research and Therapy
- Timing of expression of the core clock gene <i>Bmal1</i> influences its effects on aging and survival
- K channel therapeutics at the bedside
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Synergistic Antibacterial Activity and Wound Healing Properties of Selenium-Chitosan-Mupirocin Nanohybrid System: An in Vivo Study on Rat Diabetic Staphylococcus aureus Wound Infection Model
- Skin manifestations of obesity: a comparative study
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Metabolic Syndrome Prevalence in Psoriasis
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA